« Back
Home /
IL-1ra Antibody - Biotin Conjugated

IL-1ra Antibody - Biotin Conjugated

Item no.	OASA11646
Manufacturer	AVIVA Systems Biology
Amount	50 ug
Category	Oncology Neuroscience Neuroinflammation Metabolism Diabetes Antibodies By Cell Type Carcinoma Obesity Western Blot ELISA Primary Antibodies Immunostaining
Type	Antibody Polyclonal
Format	Lyophilized
Applications	WB, ELISA
Specific against	Human (Homo sapiens)
Host	Rabbit
Isotype	IgG
Conjugate/Tag	Biotin
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Alias	DIRA,IRAP,IL1F3,IL1RA,MVCD4,IL-1RN,IL-1ra,IL-1ra3,ICIL-1RA
Available
Manufacturer - Type	Polyclonal Antibody
Manufacturer - Category	Root Catalog/Products/Primary Antibodies
Manufacturer - Isotype	Polyclonal IgG
Manufacturer - Application Additional Information	ELISA: Suggested dilution- 0.25-1.0 ug/ml; This biotinylated human IL-1RA antibody may be used in a direct ELISA or as the detection reagent in a sandwich ELISA with a purified human IL-1RA antibody (Catalog No. OASA11645) as the capture reagent and recombinant human IL-1RA (Catalog No. OPSA10975) as the standard. Western Blot: Suggested dilution- 0.1-0.2 ug/ml; This biotinylated human IL-1RA antibody may be used in Western Blotting applications under either reducing or non-reducing conditions with recombinant human IL-1RA (Catalog No. OPSA10975) as the positive control.
Product format	Lyophilized. Phosphate buffered saline
Reconstitution and storage	-20°C
Description of target	Rabbit Anti Human Interleukin-1RA:Biotin
Protein accession_num	NP_000568.1
Protein name	Interleukin-1 receptor antagonist protein
Clonality	Polyclonal
Immunogen	Recombinant human IL-1RA (PHP080)
Homology	Human
Manufacturer - Specificity	This product specifically recognises human Interleukin-1 receptor antagonist (IL-1RA), a naturally occurring inflammatory inhibitor protein, produced by monocytes, macrophages, neutrophils, corneal epithelial cells and fibroblasts, which inhibits the activity of IL-1 alpha and IL-1 beta, by competitively blocking binding to cell surface receptors for IL-1. Genetic variations in IL-1RA gene (IL1RN) are associated with susceptibility to microvascular complications of diabetes type 4 (MVCD4), and IL-1RA has therapeutic applications in rheumatoid arthritis, asthma, psoriasis, sepsis, chronic myelogenous leukaemia and inflammatory bowel disease.
Concentration	0.1 mg/ml

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

OASA11646-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 50 ug

available

Delivery expected until 1/8/2026

Compare

Add to wishlist

Get an offer

Request delivery time